Apoptosis Assays World Market

Executive Summary

The analysts published the World Market Research Compendium on Apoptosis Assays. This report reveals that Assay Kits account for the largest share of the global demand for Apoptosis Assays by product type, which is estimated to be US$2.2 billion in 2022 and is projected to reach US$3.3 billion by 2026 at a CAGR of 10.2% between 2022 and 2026.

This world market compendium focuses at a high level analysis of the Apoptosis Assays market in terms of value in US$ for historical/current trends and forecast by Product Type - Assay Kit, Reagent, Instrument and Microplate; Detection Technology - Flow Cytometry, Cell Imaging & Analysis System, Spectrophotometry and Others; Application - Drug Discovery & Development, Clinical & Diagnostic Application, Basic Research and Stem Cell Research; End-Use Market - Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Academic & Research Institutes; Geographic Region - North America, Europe, Asia-Pacific and Rest of World.

Companies Mentioned

• Abbvie, Inc.
• Abcam PLC
• Abnova Corporation
• Amgen, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• R&D Systems, Inc.
• Novus Biologicals, LLC
• Biotek Instruments, Inc.
• Biotium, Inc.
• Canvax Biotech S.L.
• Creative Bioarray
• Danaher Corporation
• GE Healthcare
• Genecopoeia, Inc.
• Geno Technology, Inc.
• Liminal Biosciences, Inc.
• Merck KGaA
• Novartis AG
• Perkinelmer, Inc.
• Pfizer, Inc.
• Promega Corporation
• Sartorius AG
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.